RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Acute Coronary Syndrome (ACS)
Interventions
DEVICE

Drug-coated balloon

Non-culprit lesion will be pretreated before DCB treatment. The bail-out stent treatment is permitted if pretreatment failed. Individual will receive guideline-directed medical treatment.

DRUG

Guideline-directed medical treatment

All individuals will receive guideline-directed medical treatment.

Trial Locations (1)

150000

RECRUITING

The Second Affiliated Hospital of Harbin Medical University, Harbin

All Listed Sponsors
collaborator

Shanghai Shenqi Medical Technology Co., Ltd

INDUSTRY

lead

Harbin Medical University

OTHER